U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H8O4
Molecular Weight 180.1574
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ASPIRIN

SMILES

CC(=O)OC1=C(C=CC=C1)C(O)=O

InChI

InChIKey=BSYNRYMUTXBXSQ-UHFFFAOYSA-N
InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)

HIDE SMILES / InChI
Molecular Formula C9H8O4
Molecular Weight 180.1574
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:21:12 UTC 2023
Edited
by admin
on Fri Dec 15 15:21:12 UTC 2023
Record UNII
R16CO5Y76E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ASPIRIN
HSDB   MART.   MI   ORANGE BOOK   USP   USP-RS   VANDF  
Common Name English
ASPIRIN COMPONENT OF VICOPRIN
Common Name English
CLOPIDOGREL/ACETYLSALICYLIC ACID COMPONENT ASPIRIN
Brand Name English
DUOCOVER COMPONENT ASPIRIN
Brand Name English
ASPIRIN COMPONENT OF MICRAININ
Common Name English
ACETYL SALICYLATE
Systematic Name English
ASPIRIN COMPONENT OF EQUAGESIC
Common Name English
2-ACETYLOXYBENZOIC ACID
Systematic Name English
ASPIRIN [ORANGE BOOK]
Common Name English
ASPIRIN COMPONENT OF AGGRENOX
Common Name English
BAY1019036
Code English
INVAGESIC FORTE COMPONENT ASPIRIN
Common Name English
DUOPLAVIN COMPONENT ASPIRIN
Brand Name English
ASPIRIN [USP MONOGRAPH]
Common Name English
ASA
Common Name English
ASPIRIN COMPONENT OF LANORINAL
Common Name English
ACETYLSALICYLIC ACID [EMA EPAR]
Common Name English
NSC-27223
Code English
AGGRENOX COMPONENT ASPIRIN
Common Name English
CODOXY COMPONENT ASPIRIN
Common Name English
MEASURIN
Brand Name English
ASPIRIN COMPONENT OF ROXIPRIN
Common Name English
ROXIPRIN COMPONENT ASPIRIN
Common Name English
ACETYLSALICYLIC ACID [GREEN BOOK]
Common Name English
ACETYLSALICYLIC ACID (WHO-IP)
Common Name English
NORGESIC COMPONENT ASPIRIN
Common Name English
ASPIRIN COMPONENT OF ROBAXISAL
Common Name English
ASPIRIN [MART.]
Common Name English
ASPIRIN COMPONENT OF YOSPRALA
Brand Name English
ASPIRIN COMPONENT OF NORGESIC
Common Name English
MEPRO-ASPIRIN COMPONENT ASPIRIN
Common Name English
ASPIRIN COMPONENT OF CARISOPRODOL COMPOUND
Common Name English
ASPIRIN [VANDF]
Common Name English
ORPHENGESIC COMPONENT ASPIRIN
Common Name English
ASPIRIN COMPONENT OF SOMA COMPOUND
Common Name English
PRAVIGARD PAC COMPONENT ASPIRIN
Common Name English
ASPIRIN COMPONENT OF AXOTAL
Common Name English
DARVON COMPOUND COMPONENT ASPIRIN
Common Name English
ACIDUM ACETYLSALICYLICUM (WHO-IP)
Common Name English
AXOTAL COMPONENT ASPIRIN
Common Name English
INVAGESIC COMPONENT ASPIRIN
Common Name English
ASPIRIN COMPONENT OF EXCEDRIN
Common Name English
ASPIRIN COMPONENT OF INVAGESIC
Common Name English
MICRAININ COMPONENT ASPIRIN
Common Name English
ASPIRIN COMPONENT OF TALWIN COMPOUND
Common Name English
LANORINAL COMPONENT ASPIRIN
Common Name English
ASPIRIN COMPONENT OF INVAGESIC FORTE
Common Name English
SYNALGOS-DC COMPONENT ASPIRIN
Common Name English
ASPIRIN [JAN]
Common Name English
ASPIRIN COMPONENT OF MEPRO-ASPIRIN
Common Name English
ASPIRIN [USP-RS]
Common Name English
NSC-406186
Code English
BENZOIC ACID, 2-(ACETYLOXY)-
Common Name English
ASPIRIN COMPONENT OF PRAVIGARD PAC
Common Name English
FIORINAL COMPONENT ASPIRIN
Common Name English
ASPIRIN COMPONENT OF AZDONE
Common Name English
ACIDUM ACETYLSALICYLICUM
Common Name English
ASPIRIN COMPONENT OF SYNALGOS-DC
Common Name English
ASPIRIN COMPONENT OF PERCODAN
Common Name English
CARISOPRODOL COMPOUND COMPONENT ASPIRIN
Common Name English
Salicylic acid acetate
Systematic Name English
Q-GESIC COMPONENT ASPIRIN
Common Name English
Acetylsalicylic acid [WHO-DD]
Common Name English
PERCODAN-DEMI COMPONENT ASPIRIN
Common Name English
VICOPRIN COMPONENT ASPIRIN
Common Name English
ASPIRIN COMPONENT OF DUOPLAVIN
Brand Name English
ASPIRIN COMPONENT OF DUOCOVER
Brand Name English
AZDONE COMPONENT ASPIRIN
Common Name English
ACETYLSALICYLIC ACID [EP MONOGRAPH]
Common Name English
EXCEDRIN COMPONENT ASPIRIN
Common Name English
SOMA COMPOUND COMPONENT ASPIRIN
Common Name English
ASPIRIN COMPONENT OF ORPHENGESIC
Common Name English
ACETYLSALICYLICUM ACIDUM [HPUS]
Common Name English
ASPIRIN [HSDB]
Common Name English
ROBAXISAL COMPONENT ASPIRIN
Common Name English
ACETYLSALICYLIC ACID
EMA EPAR   EP   GREEN BOOK   INCI   WHO-DD  
INCI  
Official Name English
2-(ACETYLOXY)BENZOIC ACID
Systematic Name English
EQUAGESIC COMPONENT ASPIRIN
Common Name English
PERCODAN COMPONENT ASPIRIN
Common Name English
ASPIRIN COMPONENT OF CODOXY
Common Name English
ASPIRIN COMPONENT OF PERCODAN-DEMI
Common Name English
ASPIRIN [MI]
Common Name English
YOSPRALA COMPONENT ASPIRIN
Brand Name English
ORPHENGESIC FORTE COMPONENT ASPIRIN
Common Name English
ASPIRIN COMPONENT OF Q-GESIC
Common Name English
ACETYLSALICYLICUM ACIDUM
HPUS  
Common Name English
ASPIRIN COMPONENT OF FIORINAL
Common Name English
ASPIRIN COMPONENT OF ORPHENGESIC FORTE
Common Name English
ASPIRIN COMPONENT OF CLOPIDOGREL/ACETYLSALICYLIC ACID
Brand Name English
ACETYLSALICYLIC ACID [INCI]
Common Name English
DURLAZA
Brand Name English
TALWIN COMPOUND COMPONENT ASPIRIN
Common Name English
ASPIRIN COMPONENT OF DARVON COMPOUND
Common Name English
Classification Tree Code System Code
WHO-ATC C07FX02
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
CFR 21 CFR 343.13
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
CFR 21 CFR 343.12
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-VATC QN02BA51
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC C10BX01
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-VATC QB01AC56
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
LIVERTOX NBK548900
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC C10BX05
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC A01AD05
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-VATC QM01BA03
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
EMA ASSESSMENT REPORTS DUOCOVER (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC M01BA03
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
FDA ORPHAN DRUG 724719
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC C10BX04
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL/ACETYLSALICYLIC ACID (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
EMA ASSESSMENT REPORTS CLOPIDOGREL/ACETYLSALICYCLIC ACID (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC N02AJ02
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
FDA ORPHAN DRUG 764120
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-VATC QN02BA71
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-VATC QB01AC06
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
EMA ASSESSMENT REPORTS DUOPLAVIN (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-VATC QC10BX05
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
NDF-RT N0000008836
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
NDF-RT N0000000160
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
EMA ASSESSMENT REPORTS DUOPLAVIN (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 12.5
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
NDF-RT N0000008836
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC N02BA71
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC N02BA01
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
FDA ORPHAN DRUG 724619
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-VATC QC10BX02
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
FDA ORPHAN DRUG 607917
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC C10BX08
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
NDF-RT N0000175722
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
CFR 21 CFR 520.1409
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC B01AC08
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC B01AC56
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
EU-Orphan Drug EU/3/04/208
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC N02BA51
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC B01AC06
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC C10BX06
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC N02BA15
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-VATC QA01AD05
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC C10BX02
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC C10BX12
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
NDF-RT N0000175721
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
NDF-RT N0000175578
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC N02AJ07
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-VATC QC10BX01
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC N02AJ18
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
EPA PESTICIDE CODE 129061
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 7.1
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 2.1
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
CFR 21 CFR 341.40
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC C07FX03
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC C07FX04
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-VATC QN02BA01
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
EMA ASSESSMENT REPORTS DUOCOVER (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-VATC QC10BX04
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
WHO-ATC N02BA65
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
Code System Code Type Description
DRUG BANK
DB00945
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
RS_ITEM_NUM
1044006
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
MESH
D001241
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
SMS_ID
100000092077
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
DAILYMED
R16CO5Y76E
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
ECHA (EC/EINECS)
200-064-1
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
PUBCHEM
2244
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
NCI_THESAURUS
C287
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
FDA UNII
R16CO5Y76E
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
HSDB
652
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
RXCUI
1191
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
CAS
50-78-2
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
DRUG CENTRAL
74
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
RXCUI
91101
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
ALTERNATIVE
EVMPD
SUB12730MIG
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
MERCK INDEX
m2111
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY Merck Index
IUPHAR
4139
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
WIKIPEDIA
ASPIRIN
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
ASPIRIN
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY Description: Colourless crystals or a white, crystalline powder; odourless or almost odourless. Solubility: Soluble in about 300 parts of water; freely soluble in ethanol (~750 g/l) TS; soluble in ether R. Category: Analgesic; antipyretic. Storage: Acetylsalicylic acid should be kept in a tightly closed container, protected from light. Additional information: Even in the absence of light, Acetylsalicylic acid is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures. Definition: Acetylsalicylic acid contains not less than 99.0% and not more than 100.5% of C9H8O4, calculated with reference to the dried substance.
NSC
27223
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
CHEBI
15365
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
LACTMED
Aspirin
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
ChEMBL
CHEMBL25
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
NSC
406186
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
EPA CompTox
DTXSID5020108
Created by admin on Fri Dec 15 15:21:13 UTC 2023 , Edited by admin on Fri Dec 15 15:21:13 UTC 2023
PRIMARY
Related Record Type Details
Structure of ASPIRIN CALCIUM
SALT/SOLVATE -> PARENT
Structure of ASPIRIN COPPER
SALT/SOLVATE -> PARENT
Structure of ALOXIPRIN
SALT/SOLVATE -> PARENT
Structure of CARBASPIRIN CALCIUM
SALT/SOLVATE -> PARENT
Structure of ASPIRIN LYSINE
SALT/SOLVATE -> PARENT
Structure of ASPIRIN MAGNESIUM
SALT/SOLVATE -> PARENT
Structure of ASPIRIN ALUMINUM
SALT/SOLVATE -> PARENT
Structure of ASPIRIN SODIUM
SALT/SOLVATE -> PARENT
Structure of LITHIUM ACETYLSALICYLATE
SALT/SOLVATE -> PARENT
Structure of CARBASPIRIN
SALT/SOLVATE -> PARENT
Structure of ASPIRIN GLYCINE CALCIUM
SALT/SOLVATE -> PARENT
Structure of ZINC ASPIRIN
SALT/SOLVATE -> PARENT
Structure of ALUMINUM ACETYLSALICYLATE
SALT/SOLVATE -> PARENT
Related Record Type Details
Structure of GENTISIC ACID
METABOLITE -> PARENT
MAJOR
URINE
Structure of Salicylic acid
METABOLITE ACTIVE -> PARENT
MINOR
URINE
Structure of N-SALICYLOYLGLYCINE
METABOLITE INACTIVE -> PARENT
MAJOR
URINE
Structure of Aspirin Trelamine
PRODRUG -> METABOLITE ACTIVE
Related Record Type Details
Structure of SALSALATE
IMPURITY -> PARENT
IDENTIFIED AS IMPURITY E Limits: impurity E: not more than 1.5 times the area of the principal peak in the chromatogram obtained with reference solution (a) (0.15 per cent)Herbal Medicines 4th ED 2103
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 4-HYDROXYBENZOIC ACID
IMPURITY -> PARENT
IDENTIFIED AS IMPURITY A Limits: impurity A: not more than 1.5 times the area of the principal peak in the chromatogram obtained with reference solution (a) (0.15 per cent)
Structure of Salicylic acid
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 4-HYDROXYISOPHTHALIC ACID
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of Tambjamine F
IMPURITY -> PARENT
Structure of ASPIRIN ANHYDRIDE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of Salicylic acid
IMPURITY -> PARENT
ASSAY (COLORIMETRIC)
INTERNATIONAL PHARMACOPEIA
Structure of 4-HYDROXYBENZOIC ACID
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of ACETYLSALICYLSALICYLIC ACID
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of SALSALATE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 4-HYDROXYISOPHTHALIC ACID
IMPURITY -> PARENT
IDENTIFIED AS IMPURITY B Limits: impurity B: not more than 1.5 times the area of the principal peak in the chromatogram obtained with reference solution (a) (0.15 per cent)
Related Record Type Details
Structure of ASPIRIN
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966